 Treatment group and week will be fitted as categorical variables, and baseline score as a continuous covariate. The within-patient correlation will be modeled using the unstructured covariance matrix. The difference in LSM estimates between treatment groups, together with a 95 CI, will be presented. The following secondary efficacy endpoints will be considered and analyzed accordingly. 